AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1578922
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with vincristine, prednisone, and asparaginase with triple intrathecal chemotherapy (methotrexate, hydrocortisone, cytarabine) followed by intensification with moderate‐dose MTX plus cytarabine given over the first 16 months of therapy (Regimen D)
Trial: 1578922
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment approach for ALL
Trial: 3001778
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg suloctidil 3-times daily
Trial: 30771333
Drug: Monthly dosing
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly dosing of ranibizumab 0.3 mg every 4 weeks
Trial: 20088416
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (Luminal 30 mg thrice daily)
Trial: 20088416
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (herbal decoction)
Trial: 20088416
Drug: Acupuncture, Western
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture, Western medicine, Chinese medicine
Trial: 17955107
Drug: sumatriptan/naproxen sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sumatriptan/naproxen sodium (85 mg sumatriptan and 500 mg naproxen sodium)
Trial: 15491092
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5mg/day) with oral hygiene measures (group II)
Trial: 15491092
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene measures alone (group I)
Trial: 9860069
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) at doses of 75 or 150 mg daily
Trial: 7634504
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone replacement (0.125 IU/kg/week for the first month and 0.25 IU/kg/week thereafter) for 6 months
Trial: 7634504
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone replacement for 12 months
Trial: 2571434
Drug: Beta-blockers (metoprolol)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (metoprolol)
Trial: 2571434
Drug: Diuretics (thiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics (thiazide based)
Trial: 582628
Drug: Oral local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral local anaesthetic (oxethazaine)
Trial: 582628
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of local anaesthetic and alkali (Mucaine)
Trial: 12525193
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by radiation therapy (arm 1)
Trial: 12525193
Drug: Concomitant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemotherapy and radiation therapy (arm 2)
Trial: 12525193
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy alone (arm 3)
Trial: 8751270
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of metronidazole (MTN), 500 mg twice a day
Trial: 8751270
Drug: 2% clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% clindamycin (CLDM) phosphate in a vaginal cream, 5 g once a day for 7 days
Trial: 3457171
Drug: 2% sodium
RxNorm normalized name: Dextrose 5% and 0.2% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% sodium fluoride solution
Trial: 1882058
Drug: Sodium fluoride
RxNorm normalized name: Sodium Fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium fluoride (after placebo treatment)
Trial: 6979475
Drug: Cotrimoxazole (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotrimoxazole (dose ratio 3:2) for 14 days
Trial: 6979475
Drug: Cotrimole (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotrimole (dose ratio 3:2) for 14 days
Trial: 25585479
Drug: Horticultural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Horticultural therapy intervention (HT intervention) for 16 weeks, comprising 16 weekly sessions (120 min each) at the community center and 15 minutes per day at participants' homes.
Trial: 25585479
Drug: Horticultural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Horticultural therapy intervention (HT intervention) for 16 weeks.
Trial: 20706740
Drug: TENS therapy
RxNorm normalized name: Walgreens Electronic TENS Therapy Pain Relief Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TENS therapy with HAN stimulation (TENStem eco), 30 min at least two times a day for 3 weeks
Trial: 20706740
Drug: TENS therapy
RxNorm normalized name: Walgreens Electronic TENS Therapy Pain Relief Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TENS therapy with HAN stimulation (TENStem eco)
Trial: 10232294
Drug: Omega 3
RxNorm normalized name: omega 3,6
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omega 3 fatty acids (9.6 g/d)
Trial: 8911127
Drug: Psychological intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychological intervention (weekly cognitive individual psychotherapy and bimonthly family counselling)
Trial: 6218583
Drug: Clindamycin and
RxNorm normalized name: clindamycin and benzoyl peroxide KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin and aminoglycoside combination
Trial: 30563776
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg per day for 6 months
Trial: 27010235
Drug: Revexepride 0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revexepride 0.02 mg
Trial: 27010235
Drug: Revexepride 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revexepride 0.1 mg
Trial: 27010235
Drug: Revexepride 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revexepride 0.5 mg
Trial: 24778598
Drug: LMA with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LMA with cuff pressure limiting 25 cmH₂O (L group)
Trial: 10770345
Drug: 500 kcal
RxNorm normalized name: inf.formula,urea cycle disordr 6.5 gram-500 kcal/100 gram ORAL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 kcal daily of caloric supplement with peptides and medium-chain triglycerides plus a multivitamin and mineral supplement
Trial: 10770345
Drug: 500 kcal
RxNorm normalized name: inf.formula,urea cycle disordr 6.5 gram-500 kcal/100 gram ORAL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 kcal of a caloric supplement with whole protein and long-chain triglycerides plus a multivitamin and mineral supplement
Trial: 10770345
Drug: Multivitamin and
RxNorm normalized name: Multivitamin and Minerals Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin and mineral supplement only
Trial: 1678798
Drug: Porcine insulin
RxNorm normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine insulin (2.5 mU.kg‐1, min‐1)
Trial: 1678798
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (2.5 mU.kg‐1, min‐1)
Trial: 1678798
Drug: Porcine insulin
RxNorm normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine insulin and Human insulin
Trial: 6881419
Drug: Ornidazole 2
RxNorm normalized name: ornidazol
DrugBank: Ornidazole (DB13026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornidazole 2 g in two equal doses
Trial: 6881419
Drug: Tinidazole 2
RxNorm normalized name: tinidazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole 2 g in two equal doses
Trial: 27788949
Drug: Pelvic nodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic nodes and prostate radiation therapy
Trial: 27788949
Drug: Prostate-only radiation
RxNorm normalized name: Sus scrofa prostate preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostate-only radiation therapy
Trial: 27788949
Drug: Pelvic nodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic nodes radiation therapy (in low-risk subgroup)
Trial: 17272375
Drug: Early intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early intervention (EI) group received a biopsychosocial treatment including cognitive behavioral skills training and biofeedback.
Trial: 17272375
Drug: Nonintervention (NI)
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonintervention (NI) group received treatment as usual (biopsychosocial treatment).
Trial: 16055825
Drug: Psychodynamic interpersonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychodynamic interpersonal therapy (6 sessions)
Trial: 12708702
Drug: Small dose
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small dose pulsed betamethasone therapy
Trial: 12708702
Drug: Need based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Need based oral steroids
Trial: 10460365
Drug: Sequential CT
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential CT
Trial: 2564772
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of applied tension and applied relaxation
Trial: 778775
Drug: Experimental physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental physical therapy program
Trial: 778775
Drug: Control physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control physical therapy program
Trial: 20434403
Drug: Immediate surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate surgery and best medical therapy
Trial: 18215153
Drug: Levodopa-carbidopa (LC)
RxNorm normalized name: carbidopa / levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa-carbidopa (LC) with unchanged dosage
Trial: 18215153
Drug: Levodopa-carbidopa (LC)
RxNorm normalized name: carbidopa / levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa-carbidopa (LC) with reduced dosage by 15-25%
Trial: 17030687
Drug: ISIS 301012
RxNorm normalized name: ISIS-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISIS 301012 (50 to 400 mg, single dose followed by 4-week multiple dosing)
Trial: 21635675
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg prednisone
Trial: 8730339
Drug: Trimethoprim/sulfamethoxazole (T/S)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim/sulfamethoxazole (T/S) 2 x 960 mg/day in initial phase WG
Trial: 8730339
Drug: Trimethoprim/sulfamethoxazole (T/S)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim/sulfamethoxazole (T/S) 2 x 960 mg/day in generalized WG (group A)
Trial: 8730339
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further treatment after standard therapy (group B)
Trial: 8730339
Drug: Trimethoprim/sulfamethoxazole (T/S)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim/sulfamethoxazole (T/S) plus low-dose prednisone (group C)
Trial: 28004493
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration (IVH)
Trial: 1299597
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of amineptine
Trial: 6367750
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (D-penicillamine and hydroxychloroquine)
Trial: 6367750
Drug: Hydroxychloroquine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine therapy
Trial: 30101851
Drug: Febuxostat (urate-lowering
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat (urate-lowering agent)
Trial: 25316503
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (CPA) 50 mg orally twice a day for 2 weeks before operation and maintained for an extra week postoperatively
Trial: 19950088
Drug: Propafenone 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 600 mg orally as the initial therapy, with an additional dose of 300 mg after eight hours if needed.
Trial: 19950088
Drug: Quinidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (1 mg digoxin IV followed by oral loading of 400 mg followed by 200 mg every two hours).
Trial: 15179440
Drug: COX‐2‐selective inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COX‐2‐selective inhibitor rofecoxib 25 mg daily for 4 weeks
Trial: 15179440
Drug: COX‐2‐selective inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COX‐2‐selective inhibitor rofecoxib
Trial: 11453892
Drug: Propranolol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (120 mg twice daily for 7 days)
Trial: 11453892
Drug: Propranolol (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (60 mg twice daily for 7 days)
Trial: 11453892
Drug: Nadolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (80 mg twice daily for 7 days)
Trial: 9728825
Drug: Isoproterenol (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoproterenol (IV injections)
Trial: 9155503
Drug: High-carbohydrate meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-carbohydrate meal (L, 5.5 g mixed fat/meal)
Trial: 9155503
Drug: Moderately high-fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately high-fat meal (M, 33 g mixed fat/meal)
Trial: 2654171
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE), 100 mg/week
Trial: 2654171
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE), 300 mg/week
Trial: 2654171
Drug: 19-nortestosterone decanoate
RxNorm normalized name: 19-nortestosterone decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 19-nortestosterone decanoate (ND), 100 mg/week
Trial: 2654171
Drug: 19-nortestosterone decanoate
RxNorm normalized name: 19-nortestosterone decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 19-nortestosterone decanoate (ND), 300 mg/week
Trial: 31932487
Drug: LA dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LA dose
Trial: 25588930
Drug: Sustained-release methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release methylphenidate (MPH-SR) 18 to 54 mg/day for 10 weeks
Trial: 21801539
Drug: Presentation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presentation of treatment benefit using absolute terms
Trial: 21801539
Drug: Presentation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presentation of treatment harm in relative terms
Trial: 16942416
Drug: Telemedicine intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telemedicine intervention (group T) - patients reported three times weekly via a secure Internet site.
Trial: 15573017
Drug: Lavender therapy
RxNorm normalized name: LAVENDER
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lavender therapy
Trial: 1617576
Drug: Relaxing music
RxNorm normalized name: Relax-DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxing music therapy
Trial: 15573017
Drug: Lemon therapy
RxNorm normalized name: LEMON
DrugBank: Lemon (DB10538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lemon therapy
Trial: 15573017
Drug: Preferred music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preferred music therapy
Trial: 9431839
Drug: Propranolol 160
RxNorm normalized name: propranolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 160 mg daily for 7 days
Trial: 9431839
Drug: Zolmitriptan 10
RxNorm normalized name: zolmitriptan 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan 10 mg single dose
Trial: 8493214
Drug: High-dose cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cisplatin combined with ifosfamide and 5-fluorouracil
Trial: 22749632
Drug: RT +
RxNorm normalized name: CVS Yogurt + Fiber Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT + CT (radiation therapy plus cisplatin, 100 mg/m² i.v. on days 1, 22, and 43)
Trial: 22749632
Drug: RT (radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT (radiation therapy, 60 Gy in 6 weeks)
Trial: 18327362
Drug: Remifentanil (0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (0.02 mg)
Trial: 3731680
Drug: Fentanyl (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.1 mg)
Trial: 12181245
Drug: Marimastat 5
RxNorm normalized name: Marimastat
DrugBank: Marimastat (DB00786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marimastat 5 mg p.o. b.i.d. for 12 months
Trial: 12181245
Drug: Marimastat 10
RxNorm normalized name: Marimastat
DrugBank: Marimastat (DB00786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marimastat 10 mg p.o. b.i.d. for 12 months
Trial: 12181245
Drug: Marimastat 5
RxNorm normalized name: Marimastat
DrugBank: Marimastat (DB00786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marimastat 5 mg b.i.d. plus tamoxifen
Trial: 12181245
Drug: Marimastat 10
RxNorm normalized name: Marimastat
DrugBank: Marimastat (DB00786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marimastat 10 mg b.i.d. plus tamoxifen
Trial: 12181245
Drug: Marimastat 5
RxNorm normalized name: Marimastat
DrugBank: Marimastat (DB00786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marimastat 5 mg b.i.d.
Trial: 12181245
Drug: Marimastat 10
RxNorm normalized name: Marimastat
DrugBank: Marimastat (DB00786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marimastat 10 mg b.i.d.
Trial: 10194832
Drug: Rabipur vaccine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabipur vaccine, administered using the 2-1-1 schedule
Trial: 10194832
Drug: Rabipur vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabipur vaccine
Trial: 1941796
Drug: 0.4% terconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4% terconazole cream
Trial: 2381618
Drug: 0.8% terconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8% terconazole cream
Trial: 1941796
Drug: 2.0% miconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0% miconazole nitrate cream
Trial: 28834553
Drug: Exenatide (EXE)
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide (EXE) 10 μg BID
Trial: 26032655
Drug: Metformin (MET)
RxNorm normalized name: metformin / pioglitazone Oral Tablet [Actoplus Met]
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (MET) 1000 mg BID
Trial: 28834553
Drug: Metformin (MET)
RxNorm normalized name: metformin / pioglitazone Oral Tablet [Actoplus Met]
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (MET) during second 12 weeks
Trial: 17562253
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin 40 mg/m(2) and vincristine 1.4 mg/m(2) (maximum, 2 mg) plus reduced‐dose dexamethasone 40 mg orally on days 1‐4 (DVd)
Trial: 17562253
Drug: Conventional doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional doxorubicin 9 mg/m(2) per day and vincristine 0.4 mg per day continuous intravenous infusion plus reduced‐dose dexamethasone (VAd)
Trial: 14713761
Drug: Neoadjuvant or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant or adjuvant chemotherapy and radical cystectomy
Trial: 19525519
Drug: sirolimus 2
RxNorm normalized name: sirolimus 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sirolimus 2 mg/day